Arch Therapeutics $2.8 Million Registered Direct Offering
The following is a press release. FRAMINGHAM – Arch Therapeutics, Inc., a developer of novel liquid, gel and solid hemostatic
Read more
Arch Therapeutics
Framingham Company Gets Government Clearance For Gel To Treat Wounds
FRAMINGHAM – Arch Therapeutics, Inc., developer of novel liquid, gel and solid hemostatic and wound care devices, today, Dec. 17,
Read more
Framingham Company Submits Topical Gel for Wounds to FDA For Approval
FRAMINGHAM – Arch Therapeutics, Inc., a developer of novel liquid, gel and solid hemostatic and wound care devices, today, July 25,
Read more
Framingham-Based Medical Device Company Offering $6.1 Million Stock Sale
FRAMINGHAM – Arch Therapeutics, Inc. , a Framingham-based biotechnology company that develops products to stop bleeding and control leaking during surgery,
Read more